Besins Healthcare

Executive Summary

Besins Healthcare is a global, family-owned pharmaceutical company with over a century of expertise in body-identical hormone therapies. Focused on reproductive health and menopause, the company develops and manufactures patient-centric treatments that restore quality of life. Operating internationally from its headquarters in Monaco, Besins emphasizes long-term partnerships, quality, and innovation. With a workforce of 201-500 employees, the company is privately held and does not disclose financials or pipeline details publicly. Its legacy in hormone therapy positions it as a key player in women's health, though its private nature limits visibility into near-term catalysts.

Upcoming Catalysts (preview)

• Q2 2027Potential FDA/EMA approval of new body-identical hormone therapy for menopause65% success
• Q4 2026Expansion into Asian markets through regulatory submissions or partnerships50% success
• Q1 2027Publication of Phase 3 trial results for a novel reproductive health indication70% success